115610-29-2 (咖啡酸苯乙酯,Cape)

咖啡酸苯乙酯;3,4-二羟基-反式-肉桂酸苯乙酯;咖啡酸苯基乙酯;咖啡酸苯乙酯[E型];

Cape;Phenethyl caffeiate;3,4-Dihydroxy-trans-cinnamic acid phenethyl ester;(E)-phenethyl 3-(3,4-dihydroxyphenyl) acrylate;2-propenoic acid;3-(3,4-dihydroxyphenyl)-,2-phenethyl ester;Caffeic Acid 2-Phenylethyl Ester;CAFFEIC ACID PHENETHYL ESTER;caffeic acid phenylethyl ester;CAFFEICACIDPHENYLETHERESTER;CAPE,PhenethylCaffeate;KAFFEESUREPHENYLETHYLESTER;PHEN;PHENYLETHYL CAFFEATE;phenylethyl ester of caffeic acid;PRO0324;PHENETHYL 3,4-DIHYDROXYCINNAMATE;structural maintenance of chromosomes 2;Anti-SMC2 (C-terminal) antibody produced in goat;(βE)-3,4-Dihydroxybenzeneacrylic acid phenethyl ester;Caffeic acid beta-phenylethyl ester;SR-01000075785-6;115610-29-2;Phenethyl (E)-caffeate;2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, 2-phenylethyl ester, (E)-;HMS3260F20;caffeic acid phenethylester;2-phenylethyl 3-(3,4-dihydroxyphenyl)prop-2-enoate;SR-01000075785-9;Phenylethyl caffeate, (E)-;s7414;HMS1791N22;(E)-3-(3,4-Dihydroxy-phenyl)-acrylic acid phenethyl ester;104594-70-9;SR-01000075785-1;Phenylethyl 3,4-dihydroxycinnamate;NCGC00260954-01;HMS1361N22;(E)-phenethyl3-(3,4-dihydroxyphenyl)acrylate;FR102;CCG-39542;BSPBio_003586;C-1400;Caffeic acid phenethyl ester, >=97% (HPLC), powder;NCGC00093727-02;MLS000859889;DTXSID80861176;CHEBI:93478;BSPBio_001560;NCGC00093727-06;AC-8896;HMS1989N22;MLS002207297;caffeic acidphenethylester;BRD-K84709232-001-02-6;2-phenylethyl (2E)-3-(3,4-dihydroxyphenyl)acrylate;Phenethyl caffeate;BRD-K96188950-001-04-5;2-phenylethyl 3-(3,4-dihydroxyphenyl)-2-propenoate;PHENETHYL CAFFEATE (CAPE);UNII-G960R9S5SK;phenethyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate;NCGC00093727-05;AS-14021;EU-0100269;Tox21_500269;caffeic-acid-phenethyl-ester;C 8221;MFCD00866470;HY-N0274;NCGC00093727-04;Capeee;LP00269;HMS2233J04;3-(3,4-Dihydroxyphenyl)-2-propenoic acid 2-phenylethyl ester;NCGC00093727-07;AKOS015888207;CHEMBL319244;2-phenylethyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate;Caffeic acid ester;2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, 2-phenylethyl ester;NCGC00093727-03;PHENETHYL CAFFEATE [INCI];SPECTRUM1502209;NCGC00093727-08;Methanone, 1,1'-(1,2-cyclopropanediyl)bis[1-phenyl-;LS-14562;Caffeic acid-phenylethyl ester;Lopac0_000269;BDBM50029207;NCGC00093727-01;Trans-Caffeic Acid Phenethyl Ester;(E)-phenethyl 3-(3,4-dihydroxyphenyl)acrylate;2-phenylethyl caffeate;SDCCGSBI-0050257.P002;Caffeic acid phenethyl ester(CAPE);phenethyl 3-(3,4-dihydroxyphenyl)acrylate;SW219156-1;BRD-K96188950-001-02-9;HMS3402N22;caffeic acid phenylethylester;2-Phenylethyl (2e)-3-(3,4-Dihydroxyphenyl)prop-2-Enoate;CS-0008774;SMR000326751;3-(3,4-Dihydroxy-phenyl)-acrylic acid phenethyl ester;Q15410860;IDI1_034030;HMS3413D22;100981-80-4;QTL1_000016;HMS3649C16;G960R9S5SK;BCP27877;QAP;CHEBI:8062;HMS3677D22;NCGC00093727-09;NCGC00093727-16;SR-01000075785;Caffeic acid phenethyl esterCAPE; Phenylethyl caffeate;Caffeic acid-phenethyl ester;BRD-K96188950-001-15-1;1ST14259;BRD-K96188950-001-16-9;

MFCD00866470

SWUARLUWKZWEBQ-VQHVLOKHSA-N

1S/C17H16O4/c18-15-8-6-14(12-16(15)19)7-9-17(20)21-11-10-13-4-2-1-3-5-13/h1-9,12,18-19H,10-11H2/b9-7+

O(C(/C=C/C1C=CC(=C(C=1)O)O)=O)CCC1C=CC=CC=1